Liquid biopsy as a prognostic and theranostic tool for the management of pancreatic ductal adenocarcinoma.
Abstract
Pancreatic ductal adenocarcinomas (PDAC) represent one of the deadliest cancers worldwide. Survival is still low due to diagnosis at an advanced stage and resistance to treatment. Herein, we review the main types of liquid biopsy able to help in both prognosis and adaptation of treatments.Citation
Osei-Bordom DC, Sachdeva G, Christou N. Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma. Front Med (Lausanne). 2022 Jan 14;8:788869. doi: 10.3389/fmed.2021.788869Type
ArticleOther
Additional Links
https://www.frontiersin.org/journals/medicinePMID
35096878Journal
Frontiers in MedicinePublisher
Frontiers Mediaae974a485f413a2113503eed53cd6c53
10.3389/fmed.2021.788869